Oral Presentation ANZOS-Breakthrough Discoveries Joint Annual Scientific Meeting 2018

IL-22-based tissue-targeted therapeutics for type 2 diabetes (#33)

Michael McGuckin 1
  1. University of Melbourne, Parkville, VIC, Australia

To be provided